Literature DB >> 32029510

Alcohol effects on hepatic lipid metabolism.

Sookyoung Jeon1, Rotonya Carr2.   

Abstract

Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease with significant morbidity and mortality worldwide. ALD begins with simple hepatic steatosis and progresses to alcoholic steatohepatitis, fibrosis, and cirrhosis. The severity of hepatic steatosis is highly associated with the development of later stages of ALD. This review explores the disturbances of alcohol-induced hepatic lipid metabolism through altered hepatic lipid uptake, de novo lipid synthesis, fatty acid oxidation, hepatic lipid export, and lipid droplet formation and catabolism. In addition, we review emerging data on the contributions of genetics and bioactive lipid metabolism in alcohol-induced hepatic lipid accumulation.
Copyright © 2020 Jeon and Carr.

Entities:  

Keywords:  alcoholic liver disease; fatty acid oxidation; fatty acid uptake; lipid droplets; lipogenesis; steatosis

Mesh:

Substances:

Year:  2020        PMID: 32029510      PMCID: PMC7112138          DOI: 10.1194/jlr.R119000547

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  157 in total

1.  Cidea promotes hepatic steatosis by sensing dietary fatty acids.

Authors:  Linkang Zhou; Li Xu; Jing Ye; De Li; Wenshan Wang; Xuanhe Li; Lizhen Wu; Hui Wang; Feifei Guan; Peng Li
Journal:  Hepatology       Date:  2012-06-01       Impact factor: 17.425

2.  Lipidomic changes in rat liver after long-term exposure to ethanol.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Shakuntala Kondraganti; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

3.  Studies on the ethanol-induced decrease of fatty acid oxidation in rat and human liver slices.

Authors:  R Blomstrand; L Kager; O Lantto
Journal:  Life Sci       Date:  1973-10-16       Impact factor: 5.037

4.  Effects of ethanol on the metabolism of free fatty acids in isolated liver cells.

Authors:  J A Ontko
Journal:  J Lipid Res       Date:  1973-01       Impact factor: 5.922

5.  Dietary saturated fatty acids: a novel treatment for alcoholic liver disease.

Authors:  A A Nanji; S M Sadrzadeh; E K Yang; F Fogt; M Meydani; A J Dannenberg
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

6.  Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse.

Authors:  Farah Esfandiari; Valentina Medici; Donna H Wong; Soumia Jose; Maryam Dolatshahi; Eoin Quinlivan; Sanjana Dayal; Steven R Lentz; Hidekazu Tsukamoto; Yue Hua Zhang; Samuel W French; Charles H Halsted
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

7.  The effect of ethanol on fat storage in healthy subjects.

Authors:  P M Suter; Y Schutz; E Jequier
Journal:  N Engl J Med       Date:  1992-04-09       Impact factor: 91.245

8.  Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.

Authors:  Wenliang Zhang; Qian Sun; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2016-04-08       Impact factor: 3.455

Review 9.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

10.  Ethanol exposure inhibits hepatocyte lipophagy by inactivating the small guanosine triphosphatase Rab7.

Authors:  Ryan J Schulze; Karuna Rasineni; Shaun G Weller; Micah B Schott; Barbara Schroeder; Carol A Casey; Mark A McNiven
Journal:  Hepatol Commun       Date:  2017-03-10
View more
  19 in total

1.  Convergent somatic mutations in metabolism genes in chronic liver disease.

Authors:  Stanley W K Ng; Foad J Rouhani; Simon F Brunner; Natalia Brzozowska; Sarah J Aitken; Ming Yang; Federico Abascal; Luiza Moore; Efterpi Nikitopoulou; Lia Chappell; Daniel Leongamornlert; Aleksandra Ivovic; Philip Robinson; Timothy Butler; Mathijs A Sanders; Nicholas Williams; Tim H H Coorens; Jon Teague; Keiran Raine; Adam P Butler; Yvette Hooks; Beverley Wilson; Natalie Birtchnell; Huw Naylor; Susan E Davies; Michael R Stratton; Iñigo Martincorena; Raheleh Rahbari; Christian Frezza; Matthew Hoare; Peter J Campbell
Journal:  Nature       Date:  2021-10-13       Impact factor: 49.962

2.  Mice lacking α4 nicotinic acetylcholine receptors are protected against alcohol-associated liver injury.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Edilson Torres-Gonzalez; Gavin E Arteel; Jesse Roman
Journal:  Alcohol Clin Exp Res       Date:  2022-07-03       Impact factor: 3.928

3.  Reverse pharmacology of Nimbin-N2 attenuates alcoholic liver injury and promotes the hepatoprotective dual role of improving lipid metabolism and downregulating the levels of inflammatory cytokines in zebrafish larval model.

Authors:  Gokul Sudhakaran; Pandurangan Prathap; Ajay Guru; B Haridevamuthu; Raghul Murugan; Bader O Almutairi; Mikhlid H Almutairi; Annie Juliet; Pushparathinam Gopinath; Jesu Arockiaraj
Journal:  Mol Cell Biochem       Date:  2022-05-16       Impact factor: 3.842

Review 4.  Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice.

Authors:  Afroza Ferdouse; Robin D Clugston
Journal:  Front Physiol       Date:  2022-07-05       Impact factor: 4.755

5.  Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease.

Authors:  Fei Zhao; Jun Chen; Rui Guo; Jinyan Zhu; Weijia Gu; Songtao Li; Jiaomei Li
Journal:  Nutr Metab (Lond)       Date:  2022-07-05       Impact factor: 4.654

Review 6.  Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions.

Authors:  Tomas Hrncir; Lucia Hrncirova; Miloslav Kverka; Robert Hromadka; Vladimira Machova; Eva Trckova; Klara Kostovcikova; Pavlina Kralickova; Jan Krejsek; Helena Tlaskalova-Hogenova
Journal:  Microorganisms       Date:  2021-04-29

7.  Novel Diacylglycerol Acetyltransferase 2 Inhibitors for Treating Liver Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-06-22       Impact factor: 4.632

Review 8.  Experimental models of metabolic and alcoholic fatty liver disease.

Authors:  Delfin Gerard Buyco; Jasmin Martin; Sookyoung Jeon; Royce Hooks; Chelsea Lin; Rotonya Carr
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

Review 9.  Pathophysiological Aspects of Alcohol Metabolism in the Liver.

Authors:  Jeongeun Hyun; Jinsol Han; Chanbin Lee; Myunghee Yoon; Youngmi Jung
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice.

Authors:  Jason Correnti; Chelsea Lin; Jascha Brettschneider; Amy Kuriakose; Sookyoung Jeon; Eleonora Scorletti; Amanke Oranu; Dru McIver-Jenkins; Isabelle Kaneza; Delfin Buyco; Yedidya Saiman; Emma E Furth; Josepmaria Argemi; Ramon Bataller; William L Holland; Rotonya M Carr
Journal:  J Lipid Res       Date:  2020-05-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.